The 12 references without contexts in paper G. Mogilnaja M., V. Durleshter M., V. Mogilnaja L., V. Ignatenko V., Г. Могильная М., В. Дурлештер М., В. Могильная Л., В. Игнатенко В. (2014) “Муцины в оценке биологического потенциала опухоли // Mucins in assessment of tumoral biopotential” / spz:neicon:ksma:y:2014:i:4:p:88-92

1
Arnold C., Goel A., Blum H., Bocand R. molecular pathogenesis of colorectal cancer // Cancer. – 2005. – v. 104. – P. 2035–2047.
(check this in PDF content)
2
Gao Li J., He X. et al. Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at ligh-incidence area in Henan, north China // World. j. gastroenterology. – 2005. – v. 11. – P. 4634–4637.
(check this in PDF content)
3
Hollingsworth M., Swanson B. mucins in cancer: protection and control of the cell surface // Cancer. – 2004. – v. 4. – P. 45.
(check this in PDF content)
4
Hornick J., Odze R. Neoplastic precursor lesions in Barrett,s esophagus // Gastroenterol. clin. n. am. – 2007. – vol. 36. – p. 775–796.
(check this in PDF content)
5
Lau S., Weiss L., Chu P. Differential expression of mUC 1, mUC 2 and mUC 5 aC in carcinomas of various sites // am. j. clin. pathol. – 2004. – v. 122. – P. 61–69.
(check this in PDF content)
6
Lee S., Lee K., Kim S. et al. mUC 1, mUC 2 and mUC 5 aC and mUC 6 expressions in gastric carcinomas // Cancer. – 2001. – v. 92. – P. 1427–1434.
(check this in PDF content)
8
Pears A. Histochemistry. Teoretical and applied. – London,1968. – 561 p.
(check this in PDF content)
9
Sharma P., Marcon N., Wani S., Bansal A., Mathur S. et al. Non-biopsy detection of intestial metaplasia and displasia in Barrett,s esophagus: a prospective multicenter study // Endoscopy. – 2006. – v. 38. – P. 1206–1212.
(check this in PDF content)
10
Spechler S. intestinal metaplasia at the gastroesophageal junction // Gastroenterology. – 2004. – v. 126. – P. 567–575.
(check this in PDF content)
11
Srivastava G., Hornick J., Li X., Blount P., Sanchez C. et al. Extent of low-grade dysplasia is a risk factor for the development of oesophageal adenocarcinoma in Barrett,s esophagus // am. j. gastroenterol. – 2007. – v. 102. – P. 483–493.
(check this in PDF content)
12
Wang K., Sampliner R. Practice parameters commitlee of the american college of gastroenterology. Up-dated quideline 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus // am. j. gastroenterology. – 2008. – v. 103. – P. 788–797.
(check this in PDF content)
13
Xiao-Dong Bu, Nan Li, Xiao-QiangTian et al. altered expression of mUC 2 and mUC 5 aC in progression of colorectal carcinoma // World j. gastroenterology. 2010. – v. 16. – P. 4089–4094. Поступила 02.06.2014
(check this in PDF content)